Biomolecules (Dec 2022)

The Potential Utility of Circulating Oncofetal H19 Derived miR-675 Expression versus Tissue lncRNA-H19 Expression in Diagnosis and Prognosis of HCC in Egyptian Patients

  • Shimaa Abdelsattar,
  • Dina Sweed,
  • Hala F. M. Kamel,
  • Zeinab A. Kasemy,
  • Abdallah M. Gameel,
  • Hassan Elzohry,
  • Omnia Ameen,
  • Eman Ibrahim Elgizawy,
  • Ahmed Sallam,
  • Asmaa Mosbeh,
  • Mahmoud S. Abdallah,
  • Fatma O. Khalil,
  • Hiba S. Al-Amodi,
  • Sally M. El-Hefnway

DOI
https://doi.org/10.3390/biom13010003
Journal volume & issue
Vol. 13, no. 1
p. 3

Abstract

Read online

Hepatocellular carcinoma (HCC) is one of the most common cancers worldwide. Interestingly, lncRNA-H19 acts independently in HCC and influences miR-675 expressions. We aimed to assess the potential utility of tissue lncRNA-H19 versus miR-675 expressions as a non-invasive biomarker for HCC diagnosis and prognosis in Egyptian patients. Ninety-one HCC patients and 91 controls included in this study were investigated for expression of lncRNA-H19 and miR675 using RT-qPCR. Our results showed that the expression of lncRNA-H19 and microRNA-675 were higher in patients than in controls (p p p < 0.001, 0.001, respectively). Oncofetal H19-derived miR-675 expression could be considered a potential noninvasive diagnostic and prognostic biomarker, outstanding the performance of the expression of tissue lncRNA-H19 for HCC.

Keywords